MIR155HG is a prognostic biomarker and associated with immune infiltration and immune checkpoint molecules expression in multiple cancers

In recent years, immune checkpoint inhibitor has achieved remarkable success in multiple cancer treatment. However, how to pre‐judge which patients are suitable for immune checkpoint inhibitor is a difficult problem. We use the existing public bioinformatics database to comprehensively analyze the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Lirong, Chen, Zhanfei, Chen, Yiyin, Wang, Xiaoqian, Tang, Nanhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885872/
https://www.ncbi.nlm.nih.gov/pubmed/31568700
http://dx.doi.org/10.1002/cam4.2583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6885872/
https://www.ncbi.nlm.nih.gov/pubmed/31568700
http://dx.doi.org/10.1002/cam4.2583

Ejemplares similares